MICHAEL A DAVIES to Cisplatin
This is a "connection" page, showing publications MICHAEL A DAVIES has written about Cisplatin.
Connection Strength
0.069
-
Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy. Clin Cancer Res. 2010 Mar 15; 16(6):1834-44.
Score: 0.052
-
Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-a in patients with metastatic melanoma. Melanoma Res. 2014 Aug; 24(4):342-8.
Score: 0.018